RIA Intelligence

NOVAQUEST CAPITAL MANAGEMENT, L.L.C.

CRD #160359 SEC #801-73992 919-459-8620
SEC Registered Private Funds
Total AUM
$1.6B
Discretionary
$1.6B
Employees
22
Clients
--
Accounts
37
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND V, L.P.
TypePrivate Equity Fund
GAV$630.8M
Investors18
AuditorBDO CAYMAN LTD.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND V, L.P.
TypePrivate Equity Fund
GAV$630.8M
Investors18
AuditorBDO CAYMAN LTD.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND V (DELAWARE), L.P.
TypePrivate Equity Fund
GAV$386.7M
Investors6
AuditorBDO USA, P.C.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND V (DELAWARE), L.P.
TypePrivate Equity Fund
GAV$386.7M
Investors6
AuditorBDO USA, P.C.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND IV, L.P.
TypePrivate Equity Fund
GAV$158.1M
Investors36
AuditorBDO CAYMAN LTD.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND IV, L.P.
TypePrivate Equity Fund
GAV$158.1M
Investors36
AuditorBDO CAYMAN LTD.
Fund NameNQ PROJECT PHARAOH, L.P.
TypePrivate Equity Fund
GAV$138M
Investors20
Auditor--
Fund NameNQ PROJECT PHARAOH, L.P.
TypePrivate Equity Fund
GAV$138M
Investors20
Auditor--
Fund NameNOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND AGGREGATOR, L.P.
TypePrivate Equity Fund
GAV$131.8M
Investors2
Auditor--
Fund NameNOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND AGGREGATOR, L.P.
TypePrivate Equity Fund
GAV$131.8M
Investors2
Auditor--
Fund NameNOVAQUEST CO-INVESTMENT FUND VIII, L.P.
TypePrivate Equity Fund
GAV$121.1M
Investors51
Auditor--
Fund NameNOVAQUEST CO-INVESTMENT FUND VIII, L.P.
TypePrivate Equity Fund
GAV$121.1M
Investors51
Auditor--
Fund NameNOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND (DELAWARE), L.P.
TypePrivate Equity Fund
GAV$116.3M
Investors1
AuditorBDO USA, P.C.
Fund NameNOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND (DELAWARE), L.P.
TypePrivate Equity Fund
GAV$116.3M
Investors1
AuditorBDO USA, P.C.
Fund NameNOVAQUEST CO-INVESTMENT FUND XVI, L.P.
TypePrivate Equity Fund
GAV$109M
Investors20
Auditor--
Fund NameNOVAQUEST CO-INVESTMENT FUND XVI, L.P.
TypePrivate Equity Fund
GAV$109M
Investors20
Auditor--
Fund NameNQP SPV II, L.P.
TypePrivate Equity Fund
GAV$104.9M
Investors20
Auditor--
Fund NameNQP SPV II, L.P.
TypePrivate Equity Fund
GAV$104.9M
Investors20
Auditor--
Fund NameNQ PROJECT BRIDGETON, L.P.
TypePrivate Equity Fund
GAV$100.1M
Investors20
Auditor--
Fund NameNQ PROJECT BRIDGETON, L.P.
TypePrivate Equity Fund
GAV$100.1M
Investors20
Auditor--
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND IV AGGREGATOR, L.P.
TypePrivate Equity Fund
GAV$99.1M
Investors2
AuditorBDO CAYMAN LTD.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND IV AGGREGATOR, L.P.
TypePrivate Equity Fund
GAV$99.1M
Investors2
AuditorBDO CAYMAN LTD.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND VI, L.P.
TypePrivate Equity Fund
GAV$84.7M
Investors2
AuditorBDO CAYMAN LTD.
Fund NameNOVAQUEST PHARMA OPPORTUNITIES FUND VI, L.P.
TypePrivate Equity Fund
GAV$84.7M
Investors2
AuditorBDO CAYMAN LTD.
Fund NameNQP SPV I, L.P.
TypePrivate Equity Fund
GAV$71.6M
Investors51
Auditor--